These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9990604

  • 1. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.
    Best PJ, Hayes DL, Stanton MS.
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):79-85. PubMed ID: 9990604
    [Abstract] [Full Text] [Related]

  • 2. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C, Casavant D, Desai P, Moon R, Voukydis P, Pacetti P.
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [Abstract] [Full Text] [Related]

  • 3. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A, Della Bella P, Facchin D, Fattore L, Carbucicchio C, Tondo C, Lunati M, Vecchi MR, Petz E, Zecchin M.
    Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
    [Abstract] [Full Text] [Related]

  • 4. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A, Dual Chamber and VVI Implantable Defibrillator Trial Investigators.
    JAMA; 2002 Dec 25; 288(24):3115-23. PubMed ID: 12495391
    [Abstract] [Full Text] [Related]

  • 5. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M, Ansalone G, Auriti A, Magris B, Pandozi C, Altamura G.
    Am J Cardiol; 1996 Sep 12; 78(5A):116-8. PubMed ID: 8820847
    [Abstract] [Full Text] [Related]

  • 6. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł, Kornacewicz-Jach Z, Kaźmierczak J, Rzeuski R, Zielonka J, Kaliszczak R, Safranow K.
    Cardiol J; 2009 Sep 12; 16(5):432-9. PubMed ID: 19753522
    [Abstract] [Full Text] [Related]

  • 7. Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results.
    Trappe HJ, Achtelik M, Pfitzner P, Voigt B, Weismüller P.
    Am J Cardiol; 1999 Mar 11; 83(5B):8D-16D. PubMed ID: 10089834
    [Abstract] [Full Text] [Related]

  • 8. The value of DDD pacing in patients with an implantable cardioverter defibrillator.
    Geelen P, Lorga Filho A, Chauvin M, Wellens F, Brugada P.
    Pacing Clin Electrophysiol; 1997 Jan 11; 20(1 Pt 2):177-81. PubMed ID: 9121985
    [Abstract] [Full Text] [Related]

  • 9. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.
    Borne RT, Varosy P, Lan Z, Masoudi FA, Curtis JP, Matlock DD, Peterson PN.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223429. PubMed ID: 35315917
    [Abstract] [Full Text] [Related]

  • 10. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ, Worldwide Jewel AF Investigators.
    J Cardiovasc Electrophysiol; 2001 May 01; 12(5):521-8. PubMed ID: 11386511
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec 01; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R, Seidl K, Korte T, Himmrich E, Wieneke H, Schuchert A, Bauer W, Gerss J, Wollmann CG, Borggrefe M, Böcker D.
    Europace; 2007 Jul 01; 9(7):534-9. PubMed ID: 17440005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D.
    JACC Heart Fail; 2014 Dec 01; 2(6):611-9. PubMed ID: 25282033
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M.
    Circulation; 2006 Jun 27; 113(25):2871-9. PubMed ID: 16769912
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL.
    Heart Rhythm; 2012 Jan 27; 9(1):24-31. PubMed ID: 21835150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.